---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-051041"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2026-07-30T20:06:06+00:00"
generated_at: "2026-07-30T20:07:34.148728+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks schedules Q2 2026 earnings call for August 5, 2026

## Summary
- Presentation and Q&A session on Wednesday, August 5, 2026 at 4:30 p.m. ET.
- Webcast link and replay available on Ginkgo's investor relations website.
- Shareholders can submit questions via X (#GinkgoResults) or email to investors@ginkgobioworks.com.

## SEC filing metadata
- accession: 0001628280-26-051041
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2026-07-30T20:06:06+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/0001628280-26-051041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/dna-20260730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-051041
- JSON: https://secwatch.observer/filing/0001628280-26-051041.json
- Plain text: https://secwatch.observer/filing/0001628280-26-051041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.